Dermatology Times e-News:
|
You are subscribed to %%list.name%% as %%emailaddr%%. Unsubscribe.
|
to Dermatology Times e-News
|
|
|
|
|
|
Survey
This week we would like to know...
How frequently do you remind potentially at-risk patients about the dangers of indoor tanning?
Rarely
Sometimes
Often
Never
|
|
|
|
|
|
|
|
Allergan trials hair-growth drug
Irvine, Calif. — Drugmaker Allergan is recruiting volunteers for clinical trials of a hair-growth treatment based on the active ingredient in Latisse (bimatoprost ophthalmic solution, 0.03 percent), the company’s eyelash-growth treatment. Read full article. |  |
|
|
Moms start daughters tanning
Johnson City, Tenn. — Recently released survey results suggest that a significant portion of young women who regularly use tanning beds were introduced to them by their mothers, the St. Petersburg (Fla.) Times reports. Read full article.
|
|
Galderma launches bid for Q-Med
Uppsala, Sweden — Swiss pharmaceutical company Galderma is close to acquiring Q-Med, the Sweden-based maker of Botox rival Restylane (hyaluronic acid), for about $970 million, Reuters reports. Read full article.
|
|
Psoriasis, metabolic syndrome linked
Reykjavik, Iceland — Results of a new study suggest that patients — especially women — with psoriasis may be at increased risk for metabolic syndrome, MedPage Today reports. Read full article.
|
|
FDA OKs Gardasil for anal cancer
Silver Spring, Md. — The Food and Drug Administration (FDA) has approved Gardasil (human papillomavirus [HPV] quadrivalent vaccine, recombinant; Merck) for the prevention of anal cancer and associated precancerous lesions due to HPV types 6, 11, 16 and 18 in people ages 9 through 26 years, PRNewswire-USNewswire reports. Read full article.
|
|
|
|
Contact Us |
Contact a Dermatology Times editor Click Here
Contact a Dermatology Times sales representative Click Here
Learn about direct mail, reprints and classifieds in Dermatology Times Click Here |
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
